| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
61,456,000 |
| Market
Cap: |
872.06(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$4.9 - $16.15 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile CareDx together with its subsidiaries, is a medicine company focused on the discovery, development and commercialization of diagnostic solutions for transplant patients and caregivers. Co. provides testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey, and is a provider of genomics-based information for transplant patients. Co.'s commercially available testing services consist of AlloSure® Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients, AlloMap® Heart, a solution for heart transplant patients, AlloSure® Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure® Lung.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
38,810 |
106,345 |
| Total Sell Value |
$0 |
$0 |
$359,527 |
$1,585,048 |
| Total People Sold |
0 |
0 |
2 |
3 |
| Total Sell Transactions |
0 |
0 |
9 |
21 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Yee James P |
Chief Medical Officer |
• – – |
2018-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
63,102 |
|
- |
|
| Bickerstaff George |
Director |
– • – |
2018-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,197 |
52,204 |
|
- |
|
| Snyderman Ralph |
Director |
– • – |
2018-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
68,799 |
|
- |
|
| Hagstrom William A |
Director |
– • – |
2018-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
39,532 |
|
- |
|
| Cohen Fred E |
Director |
– • – |
2018-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
37,901 |
|
- |
|
| Goldberg Michael |
Director |
– • – |
2018-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
131,123 |
|
- |
|
| Bickerstaff George |
Director |
– • – |
2018-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
51,007 |
|
- |
|
| Gagnon Neil |
10% Owner |
– – • |
2018-05-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
50,000 |
878,768 |
|
- |
|
| Gagnon Neil |
10% Owner |
– – • |
2018-04-26 |
4 |
B |
$9.42 |
$95,481 |
I/I |
10,136 |
965,894 |
1.5 |
- |
|
| Goldberg Michael |
Director |
– • – |
2018-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,258 |
126,123 |
|
- |
|
| Snyderman Ralph |
Director |
– • – |
2018-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,221 |
63,799 |
|
- |
|
| Bickerstaff George |
Director |
– • – |
2018-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,221 |
46,007 |
|
- |
|
| Hagstrom William A |
Director |
– • – |
2018-04-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,373 |
34,532 |
|
- |
|
| Maag Peter |
See Remarks |
• • – |
2018-03-27 |
4 |
AS |
$7.87 |
$118,035 |
D/D |
(15,000) |
272,037 |
|
- |
|
| Maag Peter |
See Remarks |
• • – |
2018-03-20 |
4 |
OE |
$0.55 |
$27,400 |
D/D |
50,000 |
287,037 |
|
- |
|
| Maag Peter |
See Remarks |
• • – |
2018-02-14 |
4 |
OE |
$0.55 |
$49,286 |
D/D |
89,938 |
237,037 |
|
- |
|
| Yee James P |
Chief Medical Officer |
• – – |
2018-01-29 |
4 |
D |
$6.25 |
$5,031 |
D/D |
(805) |
43,102 |
|
- |
|
| Nelles Mitchell J |
Chief Operating Officer |
• – – |
2018-01-29 |
4 |
D |
$6.25 |
$5,031 |
D/D |
(805) |
79,639 |
|
- |
|
| Maag Peter |
See Remarks |
• • – |
2018-01-29 |
4 |
D |
$6.25 |
$9,063 |
D/D |
(1,450) |
147,099 |
|
- |
|
| Sninsky John Joseph |
Chief Scientific Officer |
• – – |
2018-01-29 |
4 |
D |
$6.25 |
$5,031 |
D/D |
(805) |
22,309 |
|
- |
|
| Maag Peter |
See Remarks |
• • – |
2018-01-22 |
4/A |
D |
$6.29 |
$23,437 |
D/D |
(3,726) |
148,549 |
|
- |
|
| Nelles Mitchell J |
Chief Operating Officer |
• – – |
2018-01-22 |
4/A |
D |
$6.29 |
$10,636 |
D/D |
(1,691) |
80,444 |
|
- |
|
| Maag Peter |
See Remarks |
• • – |
2018-01-22 |
4 |
D |
$6.29 |
$23,437 |
D/D |
(3,726) |
104,124 |
|
- |
|
| Yee James P |
Chief Medical Officer |
• – – |
2018-01-22 |
4 |
D |
$6.29 |
$10,636 |
D/D |
(1,691) |
43,907 |
|
- |
|
| Nelles Mitchell J |
Chief Operating Officer |
• – – |
2018-01-22 |
4 |
D |
$6.29 |
$10,636 |
D/D |
(1,691) |
71,586 |
|
- |
|
791 Records found
|
|
Page 23 of 32 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.42 (2.87%) 
